(Q48949896)

English

Persistent pro-inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment-induced depression

scientific article published on 8 December 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

Persistent pro-inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment-induced depression (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

author name string

C Krueger

1

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

K Hawkins

2

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

S Wong

3

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

M W Enns

4

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

G Minuk

5

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

J D Rempel

6

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

publication date

8 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

18

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

7

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

e284-91

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Neuropsychiatric disorders related to interferon and interleukins treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

The phenomenology and treatment of interferon-induced depression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Cerebrospinal cytokine levels in patients with acute depression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Twenty years of research on cytokine-induced sickness behavior

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Cytokine-induced sickness behaviour: mechanisms and implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Cytokines and psychopathology: lessons from interferon-alpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

American Gastroenterological Association technical review on the management of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Cytokines: abnormalities in major depression and implications for pharmacological treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

IL-10 as a mediator in the HPA axis and brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Cerebral dysfunction in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Increase in Interleukin-1β in Late-Life Depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01408.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2010.01408.X

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21143344

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48949896&oldid=2216554891"